Concepedia

Michael Visser

MV

Statistics

Publications

2

Citations

254

H-Index

2

Active since

2018

Affiliations

Novartis (United States)(Current)

Michael Visser is an author at Novartis (United States) specializing in oncology, gene expression, and antiproliferative drug action.

ORCID

Publications per year

2018–2024

2

Publications

2

Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers

Julien P. N. Papillon, Katsumasa Nakajima, Christopher D. Adair et al. · Journal of Medicinal Chemistry · 2018 · 237 citations · Full text

, , +11

Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma

Michael Visser, Julien P. N. Papillon, Michael J. Luzzio et al. · Journal of Medicinal Chemistry · 2024 · 17 citations · Full text

, , +12

1–2 of 2